TRVI·Trevi Therapeutics, Inc.

TRVI closes its 15-session tracking window at $18.51 against the $18.96 scanner reference, a complete -2.37% outcome; the fresh after-market quote is also $18.51. The original Raw Try thesis correctly identified a constructive tape above VWAP, but it also named decelerating participation and the absence of a verified catalyst as decisive caveats. The subsequent recovery attempts never produced durable follow-through, so the Mesa closes the episode as an unresolved conditional thesis rather than a confirmed continuation, and it is no longer followed.

TRVI gave back 0.60 percentage points in tracked return to -3.03% as the latest capture slipped 1.08% on just 0.10x participation. The rising EMA stack and RSI 62.52 keep a repair path visible, but price sits 0.87% below VWAP with neutral flow and a slight sector lag, so the original follow-through case remains unconfirmed.

TRVI's tracked return is unchanged at -2.43%, while the latest capture eased 0.80% on 0.94x participation. The rising EMA structure still leaves room for repair, but neutral flow, a 0.87-point sector lag and unavailable VWAP evidence keep follow-through unconfirmed.

TRVI's tracked return slipped 0.79 percentage points to -2.43%, while the current capture eased 0.80% on 0.94x participation. The rising EMA structure leaves a repair framework in place, but a neutral flow profile, a 0.87-point sector-relative lag and no current VWAP capture keep follow-through unconfirmed.

TRVI's tracked return is unchanged at -1.64% since the last public note, while the latest capture eased 0.53% on 0.61x participation. The rising EMA structure still offers a repair framework, but the stock trails its sector by 0.83 points, current VWAP is unavailable and flow is neutral, leaving follow-through unconfirmed.

TRVI's tracked return is unchanged at -1.64% since the last public note, while the latest capture eased 0.53% on 0.61x participation. The rising EMA structure still offers a repair framework, but the stock trails its sector by 0.83 points, current VWAP is unavailable and flow is neutral, leaving follow-through unconfirmed.

TRVI's tracked return fell 0.59 percentage points from the last public note to -1.64%, while the latest capture slipped 0.53% on 0.61x participation. The rising EMA structure still offers a repair framework, but neutral flow, no current VWAP reading and a 0.83-point lag versus the sector leave follow-through unconfirmed.

TRVI's tracked return was essentially unchanged, up 0.06 percentage points since the last note, while the latest capture rose 0.32% to $18.81. The rising EMA structure remains constructive, but price sat 1.05% below VWAP with only 0.10x participation and a 2.71-point sector headwind versus the market, so the repair thesis remains unconfirmed.

TRVI held its -1.11% tracked return while the latest capture rose 4.75% to $18.75 on 1.04x participation. The rising EMA structure keeps the repair thesis alive, but neutral flow, no current VWAP reading and a 2.43-point sector-relative headwind leave follow-through unconfirmed.

TRVI recovered 2.27 points in tracked return to -1.11%, with the latest quote at $18.75 up 4.75% on 1.04x participation. The rising EMA stack supports a repair attempt, but neutral flow, a 2.43-point sector-relative headwind and no current VWAP capture leave follow-through unconfirmed.

TRVI recovered 2.21 points since the last update to a -3.38% tracked return; the $18.24 capture is up 1.90% and just 0.27% above VWAP, but participation is only 0.11x and the stock remains 4.57 points behind its sector. The rising EMA stack keeps the repair case alive, while thin demand leaves follow-through unconfirmed.

TRVI is unchanged at a -5.59% tracked return on day 12, while the latest quote is $17.90, down 1.92% on 0.60x volume. The rising EMA stack remains intact and the sector-relative picture is neutral, but lighter participation and neutral accumulation leave the recovery unconfirmed; visible demand is still needed.

TRVI tracked return slipped 0.68 points from the last note to -4.91%, while the after-hours capture is $17.90, down 1.92% on 0.60x volume. The EMA stack remains rising, but the latest weakness and thin participation further weaken the repair framing; the recovery thesis still needs visible demand rather than a low-participation bounce.

TRVI gave back 0.30 percentage points to -4.91% on day 11. Price is now below the short-term EMA line and the session is down 1.21% on 0.36x relative volume, so the earlier repair framing has weakened; the recovery thesis still needs visible demand rather than a low-participation bounce.

TRVI slipped 0.87 percentage points to -4.61% on day 11; the current session is down 0.38% on 0.10x relative volume. The rising EMA structure and price above VWAP at $17.94 temper the retreat, but such light participation leaves the recovery thesis conditional.

TRVI is unchanged at -3.74% on day 11, while the current session is down 0.82% on 0.65x relative volume. The rising EMA structure and RSI at 57.95 preserve the constructive frame, but the absence of cumulative progress or stronger demand leaves the recovery thesis conditional.

TRVI remains at -3.74% on day 10, with the current session down 0.82% on 0.62x relative volume. The bullish EMA structure remains intact and RSI has improved to 57.95, but this low-participation move still does not show a higher low or renewed demand, leaving the recovery thesis conditional.

TRVI is now at -3.74% on day 10 after the latest public update gave back 0.63 percentage points, while current price is $18.25 and relative volume is 0.62x. The bullish EMA structure remains intact, but this low-participation move still does not confirm a higher low or renewed demand, so the recovery thesis remains conditional.

TRVI is now at -3.74% on day 10 after the latest public update gave back 0.63 percentage points, while current price is $18.25 and relative volume is 0.62x. The bullish EMA structure remains intact, but this low-participation move still does not confirm a higher low or renewed demand, so the recovery thesis remains conditional.

TRVI is now at -3.11% on day 10 after the latest session eased 0.30%, with relative volume falling to 0.39x while the bullish EMA structure remains intact. The recovery thesis is still conditional: price has not broken the structure, but this low-participation move does not add evidence of a higher low or renewed demand.

TRVI is now at -3.11% on day 10 after the latest session eased 0.30%, with relative volume falling to 0.39x while the bullish EMA structure remains intact. The recovery thesis is still conditional: price has not broken the structure, but this low-participation move does not add evidence of a higher low or renewed demand.

TRVI is now at -3.85% on day 10 after the latest session slipped 0.60%, with only 0.07x relative volume despite a bullish EMA stack. The recovery thesis remains conditional: the structure has not broken, but this low-participation move does not confirm a higher low or renewed demand.

TRVI is now at -3.85% on day 10 after the latest session slipped 0.60%, with only 0.07x relative volume despite a bullish EMA stack. The recovery thesis remains conditional: the structure has not broken, but this low-participation move does not confirm a higher low or renewed demand.

TRVI now tracks at -2.95% on day 10 after a quiet session with a 1.71% gain and 0.7x relative volume. The bullish structure is still visible, but the absence of strong participation and a confirmed higher low keeps the recovery thesis conditional; the next check is sustained demand while that structure holds.

TRVI now tracks at -2.95% on day 10 after a quiet session with a 1.71% gain and 0.7x relative volume. The bullish structure is still visible, but the absence of strong participation and a confirmed higher low keeps the recovery thesis conditional; the next check is sustained demand while that structure holds.

TRVI gave back 0.84 percentage points from the last public update and now tracks at -2.95%. The current session remains constructive above the reference structure, but lighter participation and the absence of a confirmed higher low keep the recovery thesis conditional; the next check is sustained demand while that structure holds.

TRVI gave back 0.84 percentage points from the last public update and now tracks at -2.95%. The current session remains constructive above the reference structure, but lighter participation and the absence of a confirmed higher low keep the recovery thesis conditional; the next check is sustained demand while that structure holds.

TRVI recovered 1.53 percentage points since the last public update, narrowing its tracking loss to -2.11%. That relief keeps the conditional thesis alive but does not yet establish a higher low; the next check is sustained participation while the recovery structure holds.

TRVI recovered 1.53 percentage points since the last public update, narrowing its tracking loss to -2.11%. That relief keeps the conditional thesis alive but does not yet establish a higher low; the next check is sustained participation while the recovery structure holds.

TRVI has recovered 0.95 percentage points since the last public update and now stands at -3.64% in tracking. The relief thesis remains conditional; the next check is whether a higher low develops with sustained participation.

TRVI has recovered 0.95 percentage points since the last public update and now stands at -3.64% in tracking. The relief thesis remains conditional; the next check is whether a higher low develops with sustained participation.

TRVI remains at -4.59% in tracking, with no additional return change since the last public update. The conditional relief thesis remains unresolved; the next check is whether a higher low develops with sustained participation.

TRVI remains at -4.59% in tracking, with no additional return change since the last public update. The conditional relief thesis remains unresolved; the next check is whether a higher low develops with sustained participation.

TRVI is now at -4.59% in tracking, a -1.11 percentage-point change versus the last public update. The next check is whether this move holds with continued participation while the published thesis remains conditional.

TRVI is now at -4.59% in tracking, a -1.11 percentage-point change versus the last public update. The next check is whether this move holds with continued participation while the published thesis remains conditional.

TRVI slipped 0.68 percentage points to a prepared return of -3.48% since the previous public update. The relief thesis remains conditional, and the next confirmation is a higher low with visible participation.

TRVI slipped 0.68 percentage points to a prepared return of -3.48% since the previous public update. The relief thesis remains conditional, and the next confirmation is a higher low with visible participation.

TRVI is unchanged at a prepared return of -2.80%, with price above VWAP but time-adjusted relative volume at 0.86x. The relief thesis remains conditional; a higher low with visible participation is still the next confirmation.

TRVI is unchanged at a prepared return of -2.80%, with price above VWAP but time-adjusted relative volume at 0.86x. The relief thesis remains conditional; a higher low with visible participation is still the next confirmation.

TRVI remains at a prepared return of -2.80%, with price above VWAP but time-adjusted relative volume at 0.86x. The relief thesis is still conditional; a higher low with visible participation is the next confirmation.

TRVI remains at a prepared return of -2.80%, with price above VWAP but time-adjusted relative volume at 0.86x. The relief thesis is still conditional; a higher low with visible participation is the next confirmation.

TRVI recovered 0.52 percentage points to a prepared return of -3.32%; price is above VWAP, but time-adjusted relative volume is 0.86x and does not yet show clear demand. The relief thesis remains conditional on a higher low with visible participation.

TRVI recovered 0.52 percentage points to a prepared return of -3.32%; price is above VWAP, but time-adjusted relative volume is 0.86x and does not yet show clear demand. The relief thesis remains conditional on a higher low with visible participation.

TRVI improved from -4.35% to -4.43%, effectively unchanged at $18.12 versus $18.14 in the previous public note. The post-reconstitution relief thesis remains conditional: price structure needs a higher low and visible demand, with no fresh issuer-specific event supplying a new explanation.

TRVI improved from -4.35% to -4.43%, effectively unchanged at $18.12 versus $18.14 in the previous public note. The post-reconstitution relief thesis remains conditional: price structure needs a higher low and visible demand, with no fresh issuer-specific event supplying a new explanation.

TRVI improved from -4.35% to -4.43%, effectively unchanged at $18.12 versus $18.14 in the previous public note. The post-reconstitution relief thesis remains conditional: price structure needs a higher low and visible demand, with no fresh issuer-specific event supplying a new explanation.

TRVI improved from -4.35% to -4.43%, effectively unchanged at $18.12 versus $18.14 in the previous public note. The post-reconstitution relief thesis remains conditional: price structure needs a higher low and visible demand, with no fresh issuer-specific event supplying a new explanation.

TRVI recovered from -11.08% to -8.11%, moving from $17.54 to $18.12, but the post-reconstitution relief thesis still needs a higher low and tighter base with visible demand. No fresh issuer-specific event is available, so price structure remains the next confirmation rather than a new explanation.

TRVI recovered from -11.08% to -8.11%, moving from $17.54 to $18.12, but the post-reconstitution relief thesis still needs a higher low and tighter base with visible demand. No fresh issuer-specific event is available, so price structure remains the next confirmation rather than a new explanation.

TRVI is now -4.35%, a 6.73-point recovery from the prior -11.08% note, with the latest public price at $18.14 versus $17.54. The post-reconstitution relief thesis is repairing, but it still needs a higher low and visible demand; no fresh issuer-specific event provides a new explanation.

TRVI is now -4.35%, a 6.73-point recovery from the prior -11.08% note, with the latest public price at $18.14 versus $17.54. The post-reconstitution relief thesis is repairing, but it still needs a higher low and visible demand; no fresh issuer-specific event provides a new explanation.

TRVI is now -11.08%, a 2.26-point recovery from the previous public note, but the post-reconstitution relief thesis still needs a higher low and tighter base with visible demand. No fresh issuer-specific event is available, so the next confirmation remains price structure rather than a new explanation.

TRVI is now -11.08%, a 2.26-point recovery from the previous public note, but the post-reconstitution relief thesis still needs a higher low and tighter base with visible demand. No fresh issuer-specific event is available, so the next confirmation remains price structure rather than a new explanation.

TRVI is now -11.08%, a 2.26-point recovery from the previous public note, but the post-reconstitution relief thesis still needs a higher low and tighter base with visible demand. No fresh issuer-specific event is available, so the next confirmation remains price structure rather than a new explanation.

TRVI is now -11.08%, a 2.26-point recovery from the previous public note, but the post-reconstitution relief thesis still needs a higher low and tighter base with visible demand. No fresh issuer-specific event is available, so the next confirmation remains price structure rather than a new explanation.

TRVI weakened from -8.44% to -10.68%, a 2.24-point deterioration since the previous public note. Price remains below VWAP near the session low, with 0.78 time RVOL decelerating; no fresh issuer event is available, so the published thesis remains under pressure without a new causal explanation.

TRVI weakened from -8.44% to -10.68%, a 2.24-point deterioration since the previous public note. Price remains below VWAP near the session low, with 0.78 time RVOL decelerating; no fresh issuer event is available, so the published thesis remains under pressure without a new causal explanation.

TRVI was unchanged at -8.44% versus the previous public note. It remains above VWAP near the upper range, but relative volume is only 0.25 and no issuer-specific event is present, so the published reading stays unchanged for this update.

TRVI was unchanged at -8.44% versus the previous public note. It remains above VWAP near the upper range, but relative volume is only 0.25 and no issuer-specific event is present, so the published reading stays unchanged for this update.

TRVI was effectively unchanged at -8.44% from its reference, a 0.19-point move from the prior public update, while observed participation remained light. With no fresh issuer event or structure improvement, the recovery thesis stays conditional on a sustained higher low and stronger demand rather than this isolated reading.

TRVI was effectively unchanged at -8.44% from its reference, a 0.19-point move from the prior public update, while observed participation remained light. With no fresh issuer event or structure improvement, the recovery thesis stays conditional on a sustained higher low and stronger demand rather than this isolated reading.

TRVI fell from -4.11% to -8.25%, a 4.14-point setback that put the tape below VWAP near the bottom of its range while participation stayed weak. The published recovery thesis is therefore a failed repair attempt for now, not a reselected outcome; a sustained reclaim with a higher low and stronger participation would be needed to restore it.

TRVI remains at $18.18 and -4.11%, holding the improved return described in the previous note but without a new structure or issuer catalyst to confirm continuation. The panel keeps the recovery thesis conditional: a defended higher low with participation-backed follow-through would strengthen it, while loss of the reclaimed area would return supply to control.

TRVI is -4.11% from its reference, improved by 2.64 points versus the previous public note. No new attributed catalyst or material structure change is available in this refresh, so the working thesis is unchanged; a panel update needs a clearer price, participation or information shift.

TRVI has rebounded to $17.68 and is back around VWAP after the prior seller-controlled session, with the tape in the upper 78% of its range and intraday participation improving. The post-reconstitution relief thesis gets a repair attempt, not a clean continuation signal: holding this reclaimed area with follow-through would help, while a loss of VWAP would return supply to control.

TRVI has rebounded to $17.68 and is back around VWAP after the prior seller-controlled session, with the tape in the upper 78% of its range and intraday participation improving. The post-reconstitution relief thesis gets a repair attempt, not a clean continuation signal: holding this reclaimed area with follow-through would help, while a loss of VWAP would return supply to control.

TRVI has moved from +3.16% at $19.56 in the prior note to -4.75% at $18.06, so the earlier above-VWAP observation no longer has the benefit of the doubt. The desk keeps the Raw Try conditional rather than falsified: reclaiming and holding the $18.96 reference is the first repair test, but a bounce still needs fresh sponsorship before it restores the follow-through case.

TRVI has moved from +3.16% at $19.56 in the prior note to -4.75% at $18.06, so the earlier above-VWAP observation no longer has the benefit of the doubt. The Mesa keeps the Raw Try conditional rather than falsified: reclaiming and holding the $18.96 reference is the first repair test, but a bounce still needs fresh sponsorship before it restores the follow-through case.

TRVI has moved from +3.16% in the last note to -4.75% at $18.06, reversing the early above-VWAP observation and putting the Raw Try back under pressure. No new verified issuer catalyst explains the shift, so the panel does not upgrade the thesis: a reclaim and hold above the $18.96 reference would be the first repair signal; continued weakness keeps the follow-through case invalidated.

TRVI is +3.16% at 19.56 against the 18.96 reference, keeping the initial above-VWAP trajectory constructive, but no independent catalyst has appeared and participation deceleration remains unresolved. The panel keeps the Raw Try observational: sustained VWAP and upper-range strength would support follow-through, while loss of VWAP or the recent intraday floor would invalidate it.